Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
27 01 2022
27 01 2022
Historique:
pubmed:
22
10
2021
medline:
9
2
2022
entrez:
21
10
2021
Statut:
ppublish
Résumé
Phosphoinositide-3-kinase γ (PI3Kγ) is highly expressed in immune cells and promotes the production and migration of inflammatory mediators. The inhibition of PI3Kγ has been shown to repolarize the tumor immune microenvironment to a more inflammatory phenotype, thereby controlling immune suppression in cancer. Herein, we report the structure-based optimization of an early lead series of pyrazolopyrimidine isoindolinones, which culminated in the discovery of highly potent and isoform-selective PI3Kγ inhibitors with favorable drug-like properties. X-ray cocrystal structure analysis, molecular docking studies, and detailed structure-activity relationship investigations resulted in the identification of the optimal amide and isoindolinone substituents to achieve a desirable combination of potency, selectivity, and metabolic stability. Preliminary
Identifiants
pubmed: 34672584
doi: 10.1021/acs.jmedchem.1c01153
doi:
Substances chimiques
Amides
0
Phosphoinositide-3 Kinase Inhibitors
0
Pyrimidines
0
Class Ib Phosphatidylinositol 3-Kinase
EC 2.7.1.137
PIK3CG protein, human
EC 2.7.1.137
pyrimidine
K8CXK5Q32L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM